Bbr Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Bbr Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $317,650 - $344,875	450 New	450 $324,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $1.94 Million - $2.68 Million	-6,467 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$335.82 - $403.04 $2.17 Million - $2.61 Million	6,467 New	6,467 $2.42 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Bbr Partners, LLC with notifications on news.